(Q38010677)

26 August 2017

Drug-based optical agents: infiltrating clinics at lower risk (English)

1 reference

26 August 2017

Markus Schwaiger

4

0 references

Vasilis Ntziachristos

series ordinal

5

object named as

Vasilis Ntziachristos

1 reference

26 August 2017

Werner Scheuer

1

1 reference

26 August 2017

Gooitzen M van Dam

series ordinal

2

1 reference

26 August 2017

Michael Dobosz

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 May 2012

1 reference

Science Translational Medicine

26 August 2017

1 reference

26 August 2017

4

1 reference

26 August 2017

134

1 reference

26 August 2017

134ps11

1 reference

Going deeper than microscopy: the optical imaging frontier in biology

26 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Building and breeding molecules to spy on cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Imaging in the era of molecular oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Molecular imaging by means of multispectral optoacoustic tomography (MSOT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Intravenous and indocyanine green angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

The phase 0 microdosing concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

Approaches using molecular imaging technology -- use of PET in clinical microdose studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003572

10.1126/SCITRANSLMED.3003572

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference